Avenir Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 1996.
1996 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Avenir Pharmaceuticals Private Limited

Avenir Pharmaceuticals Private Limited, a struck off private limited company, was established on 20 February 1996 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397DL1996PTC076498. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Pooran Singh (Director), Hargobind Singh (Director). Past directors included Sanjay Singh. Its latest AGM occurred on 30 September 2011, with the balance sheet filed on 31 March 2011. It is based at 260 Prakash Mohalla East Of Kailash, New Delhi, Delhi, 110065.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397DL1996PTC076498

  • Registration Number

    076498

  • Incorporation Date

    20 February 1996

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 30 Year, 1 Month
  • Last Filing with ROC 31 Mar 2011
Company report

Avenir Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Avenir Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Avenir Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pooran Singh Director 01 Apr 2008 Current
Hargobind Singh Director 01 Sep 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Apr 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Avenir Pharmaceuticals.

Enhance accessibility to Avenir Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Avenir Pharmaceuticals revenue growth over time
Avenir Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Avenir Pharmaceuticals?

Unlock access to Avenir Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Avenir Pharmaceuticals?

Unlock and access historical data on people associated with Avenir Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Avenir Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avenir Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Avenir Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Avenir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Avenir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Pooran Singh was appointed as a Director was appointed as a Director on 01 Apr 2008 & has been associated with this company since 18 years 17 days . was documented.

  • Director Appointment

    Progress on Hargobind Singh was appointed as a Director was appointed as a Director on 01 Sep 2006 & has been associated with this company since 19 years 7 months . was documented.

  • Company Incorporation

    Progress on Avenir Pharmaceuticals Private Limited was registered on 20 Feb 1996 with Roc Delhi & aged 30 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Avenir Pharmaceuticals Private Limited?

The CIN of Avenir Pharmaceuticals Private Limited is U51397DL1996PTC076498.

Where is Avenir Pharmaceuticals Private Limited headquartered?

Avenir Pharmaceuticals Private Limited is headquartered at 260 Prakash Mohalla East Of Kailash, New Delhi, Delhi, 110065.

When was Avenir Pharmaceuticals Private Limited incorporated?

Avenir Pharmaceuticals Private Limited was incorporated on 20 February 1996.

Who are the current directors of Avenir Pharmaceuticals Private Limited?

The current directors of Avenir Pharmaceuticals Private Limited are

What is the primary industry of Avenir Pharmaceuticals Private Limited?

The primary industry of Avenir Pharmaceuticals Private Limited is Pharma.

Is Avenir Pharmaceuticals Private Limited a listed company?

Avenir Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Avenir Pharmaceuticals Private Limited?

The authorized capital of Avenir Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available